Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F3TVB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $12,467.00 by the Defense Logistics Agency on January 16, 2026, for the supply of Skyrizi 150 mg/ml pen injections. This competitively awarded contract contains no set-aside designation and is scheduled for completion by January 20, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 vehicle valued through December 2026 that serves as the primary mechanism for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Skyrizi is a dermatological biologic medication used to treat conditions such as plaque psoriasis and Crohn's disease. As a major pharmaceutical distributor serving federal medical procurement needs, Amerisourcebergen demonstrates significant capability in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains for military and veteran healthcare systems. The company's extensive federal contract portfolio reflects its consistent performance in delivering both brand-name and generic medications to government agencies through open competition, supporting critical medical supply chain operations for the Defense Logistics Agency's medical support mission.
Quick answers
Who was awarded contract SPE2DR26F3TVB?
SPE2DR26F3TVB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F3TVB worth?
The government has obligated $12,467 on SPE2DR26F3TVB.
Is contract SPE2DR26F3TVB an order under another contract?
Yes. SPE2DR26F3TVB is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TVB competed?
The extent of competition for SPE2DR26F3TVB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award